Survival prediction in patients treated by FOLFIRI and bevacizumab for metastatic colorectal cancer (PRODIGE 9) using contrast-enhanced CT texture analysis (SPECTRA). Robotic vs. laparoscopic vs. open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results